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Abstract
Vascularization is a fundamental prerequisite for large bone construct development and remains 
one of the main challenges of bone tissue engineering. Our current study presents the combination 
of 3D printing technique with a hydrogel-based prevascularization strategy to generate 
prevascularized bone constructs. Human adipose derived mesenchymal stem cells (ADMSC) and 
human umbilical vein endothelial cells (HUVEC) were encapsulated within our bioactive 
hydrogels, and the effects of culture conditions on in vitro vascularization were determined. We 
further generated composite constructs by forming 3D printed polycaprolactone/hydroxyapatite 
scaffolds coated with cell-laden hydrogels and determined how the co-culture affected 
vascularization and osteogenesis. It was demonstrated that 3D co-cultured ADMSC-HUVEC 
generated capillary-like networks within the porous 3D printed scaffold. The co-culture systems 
promoted in vitro vascularization, but had no significant effects on osteogenesis. The 
prevascularized constructs were subcutaneously implanted into nude mice to evaluate the in vivo 
vascularization capacity and the functionality of engineered vessels. The hydrogel systems 
facilitated microvessel and lumen formation and promoted anastomosis of vascular networks of 
human origin with host murine vasculature. These findings demonstrate the potential of 
prevascularized 3D printed scaffolds with anatomical shape for the healing of larger bone defects.
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INTRODUCTION
Bone grafts are commonly used for the treatment of acquired and congenital bone defects 
resulting from tumor resections, trauma, infections, cysts, and bone clefts.1,2 >500,000 bone 
grafting procedures are performed annually in the United States, with a cost of over $2.5 
billion.3 Currently, the gold standard is autogenous bone, however, allogenic and xenogenic 
bone grafts are commonly used as well.4 Limitations in bone graft volume, donor site 
morbidity, potential for disease transmission, and inconsistent integration with the host 
tissue are all potential drawbacks to bone grafting.2
Bone tissue engineering (BTE) holds the promise to enhance bone formation and 
regeneration by harnessing innovative scaffolds, stem cells, and biological factors.5,6 
Traditionally, BTE focused more on scaffold fabrication, stem cell differentiation, and 
growth factor release. However, more evidence has shown that the lack of vascularization 
within the engineered bone grafts can inhibit osteogenesis and host integration, thus 
inhibiting the healing of large bone defects.7,8 Several strategies have been explored in vitro 
and in vivo for generating vascularized bone grafts, including growth factors or other 
biochemical angiogenic stimulation,2,9 dynamic culture,10 co-culture of endothelial cells 
with mesenchymal stem cells (MSC),11,12 in vivo arteriovenous loops13,14 and 
immunomodulation of adaptive immune cells.15 The survival and function of engineered 
bone constructs after subsequent implantation is highly reliant on the speed in which they 
can develop adequate vascularization.16,17 This is why increasing BTE efforts are needed to 
develop advanced bone scaffolds in parallel with the innovations in vascular tissue 
engineering.13
Another important aspect for BTE is to control the scaffold properties and fabrication. 
Among various bone tissue engineered scaffold fabrication techniques, 3D printing is a 
particularly promising technology.18,19 3D printing (or addictive manufacturing) employs 
automatic fabrication processes and thermoplastic biomaterials, like polycaprolactone 
(PCL). It enables the creation of 3D scaffolds with controllable pore size, porosity, and 
internal architecture in a layer-by-layer manner.20,21 Importantly, 3D printing techniques can 
implement imaging techniques like computed tomography (CT) and magnetic resonance 
imaging (MRI) to generate patient specific 3D tissue models.22,23 This will provide a 
blueprint for fabricating customized bone scaffolds with accurate anatomical shapes to fill 
the defect sites.
Therefore, combining 3D printed bone scaffolds with prevascularization strategies could 
ensure the appropriate size and shape of the forming bone, as well as the establishment of a 
vascular supply throughout the graft. Some efforts have been made to achieve this goal. 
Wang et al. subcutaneously implanted 3D printed porous poly(propylene fumarate) (PPF) 
scaffolds with a variety of combinations of pore sizes and porosities in a rat model to 
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evaluate vascular ingrowth and angiogenesis.24 The in silico model demonstrated that 
vascularization decreases with increasing pore size (from 200 to 800 μm, with constant 
porosity) or increasing wall thickness. However, acellular scaffolds without any growth 
factor or physical stimuli cannot be fully vascularized. Mao’s group integrated Arg-Gly-Asp 
(RGD)-phage nanofibers into the pores of 3D printed biphasic calcium phosphate scaffolds 
to induce the regeneration of vascularized bone in vivo.25 The RGD-phage can regulate the 
endothelial cell (EC) migration and adhesion to induce endothelialization, while 
simultaneously activating osteoblastic differentiation of MSC. Mishra and co-workers 
developed a composite scaffold system of a 3D printed PPF shell and fibrin hydrogel with an 
MSC/human umbilical vein endothelial cell (HUVEC) spheroid.26 Prevascularization 
conditioning shortened the neovascularization process, while the presence of the MSC/
HUVEC spheroid assisted vascular infusion. However, single MSC/HUVEC spheroids 
resulted in uneven vasculature and rarely formed the complete vascularization needed for a 
larger bone defect. These methods for producing prevascularization in bone scaffolds need 
to be expanded on.
In our current study, we first encapsulated human adipose derived MSC (ADMSC) and 
HUVEC within chemically functionalized bioactive hydrogels consisting of hyaluronic acid 
(HA) and gelatin and co-cultured the constructs in hybrid media (consisting of growth 
medium for ADMSC and endothelial cell medium). Then, ADMSC-HUVEC laden 
hydrogels were formed around 3D printed PCL/hydroxyapatite (HAp) scaffolds and 
conditioned in hybrid media for 3 weeks to assess the effects of co-culture on 
vascularization and ADMSC osteogenic differentiation within the constructs. We further 
implanted bone constructs subcutaneously into athymic mice to determine the EC-MSC 
interactions in vivo and compared functionality of engineered vessels in various scaffolds.
MATERIALS AND METHODS
Cell culture and differentiation
Established primary human ADMSC were purchased from Lonza and cultured in growth 
medium (GM) containing DMEM/F12 medium (Invitrogen), 10% FBS (Invitrogen) and 1% 
P/S (Invitrogen). For osteogenic differentiation, osteogenic medium (OGM) consisted of 
GM, 100 nM dexamethasone (Sigma), 10 mM β-glycerophosphate (Sigma) and 50 μM 
ascorbic acid (Sigma).27 HUVEC (Lonza) were grown in EGM (EGM-2 BulletKit, Lonza) 
used until passage 6. The cells were cultured in 5% CO2 at 37°C. ADMSC or ADMSC/
HUVEC spheroids were prepared by the hanging drop method. Briefly, 20 μL of cell 
resuspension (ADMSC, or ADMSC: HUVEC = 1:1), with a density of 5 × 106 cells/ml was 
placed onto the lid of 48-well plate and cultured overnight.
Polymer modification and hydrogel preparation
Photocrosslinkable HA (NovaMatrix, fermented from Streptococcus zooepidemicus, ~1200 
kDa) and gelatin (Type B from bovine skin, Sigma) were synthesized as previously 
reported28 through the reaction of methacrylic anhydride (Sigma) with 0.5% HA or 10% 
gelatin in deionized water. For hydrogel preparation, methacrylated HA (Me-HA), 
0.75%w/v and methacrylated gelatin (Me-Gel), 1.5%w/v were dissolved in cell culture 
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medium with 0.05% w/v 2-hydroxy-1(4-(hydroxyethox)phenyl)-2-methyl-1-propanone 
(Irgacure 2959; CIBA Chemicals) and homogeneous cell suspension [totally 4 × 106 
cells/ml, ADMSC:HUVEC = 1:1, Figure 1(A)] or cell spheroid encapsulation [Figure 1(B)]. 
The hydrogel precursor was transferred into silicone molds (8 mm in diameter, 1 mm in 
thickness, for cell and spheroid encapsulation) and subsequently exposed to OmniCure 
S2000 UV lamp (Lumen Dynamics, 365 nm) for 60 s at room temperature.
3D printing and scaffold characterization
PCL/HAp nanocomposite scaffolds were 3D printed using the 3D Bioplotter (EnvisionTEC, 
Germany). PCL pellets (Sigma, Mw = 65,000) and HAp nanocrystal (100 nm, Berkeley 
Advacned Biomaterials, Inc; 10% of PCL,) were air dried at 37°C overnight and then loaded 
in the stainless steel syringe with 22 G metal tip and heated at a temperature of 140°C for 10 
min. As PCL reached the molten phase, the temperature was maintained at 120°C during 
printing. A pressure of 3–3.5 bar was applied to the syringe and deposition speed of 1.8–2.2 
mm/s was used. 3D cylinder scaffold (8 mm in diameter and 2 mm in thickness) was 
designed using VisualMachines software (EnvisionTEC), and the design file was loaded into 
the 3D printer. PCL/HAp was deposited at different angles (0° and 90°) between two 
successive layers. A scanning electron microscope (SEM, FEI Quanta 200) was used to 
characterize surface morphology of 3D printed PCL/HAp scaffolds. The uniaxial 
compression testing of PCL and PCL/HAp was conducted using an MTS machine 
(INSTRON 8500 Plus, 25 KN) at a loading rate of 0.015 mm/s at room temperature. Before 
cell encapsulation or cell seeding, the 3D printed PCL/HAp scaffolds were disinfected in 
70% (v/v) ethanol overnight, and then were incubated in GM overnight, after being washed 
in phosphate buffered saline solution (PBS). For surface seeding, totally 8 × 105 cells 
(ADMSC:HUVEC = 1:1) were suspended in 200 μL hybrid medium and were seeded onto 
the PCL/HAp scaffolds. ADMSC or ADMSC plus HUVEC (1:1) with the same cell density 
were encapsulated within the hydrogel, then the hydrogel with cells (200 μL) was deposited 
around the printed PCL/HAp scaffolds, allowing it to settle into the scaffold before UV 
crosslinking in the manner mentioned above in Section 2.2 [Figure 1(C)]. After cell seeding 
or encapsulation, the constructs were cultured in hybrid media with OGM and EGM (OGM: 
EGM = 1:1) for 21 days.
Alkaline phosphatase (ALP) staining and activity
Alkaline phosphatase leukocyte kit (Sigma) was used according to the manufacturer’s 
protocol for ALP staining. ALP activity quantification was performed as previously 
described.28 Briefly, the lysed cells were mixed with ALP substrate solution containing p-
nitrophenyl phosphate (pNPP) (Sigma) at 37°C for 25 min. The reaction was stopped by the 
addition of NaOH, then the production of p-nitrophenol in the presence of ALPase was 
measured by monitoring the absorbance of the solution at a wavelength of 405 nm using a 
microplate reader (Bio-Tek Instruments). The total protein content was determined using a 
BCA assay kit (Pierce, Rockford, IL, USA) with bovine serum albumin as a standard, and 
the ALP activity was expressed as μmol of p-nitrophenol formation per minute per milligram 
of total proteins (μmol/min/mg protein).
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RNA isolation and qPCR
Total RNA was extracted from the whole cell-laden constructs, without separating the co-
cultured cells, using QIA-Shredder and RNeasy mini-kits (QIAgen), according to the 
manufacturer’s instructions. Total RNA was synthesized into first strand cDNA in a 20 μL 
reaction using an iScript cDNA synthesis kit (BioRad Laboratories). Real-time PCR analysis 
was performed in a StepOnePlus™ Real-Time PCR System (Thermo Scientific) using 
SsoAdvanced SYBR Green Supermix (Bio-Rad). cDNA samples were analyzed for the gene 
of interest and for the housekeeping gene 18 S rRNA. The level of expression of each target 
gene was calculated using comparative Ct (2 −ΔΔCt) method.28,29 All primers used in this 
study are listed in Supporting Information Table S1.
In vivo subcutanous implantation
Eight-week old, female athymic nude mice were purchased from Jackson Laboratory. The 
mice were housed in compliance with the University of Nebraska Medical Center (UNMC) 
guidelines. All surgery procedures were reviewed and approved by UNMC Animal Care and 
Use Committee. The cell laden constructs (scaffold with ADMSC encapsulation, scaffold 
with surface seeded ADMSC + HUVEC, and scaffold with ADMSC + HUVEC 
encapsulation) were conditioned in hybrid media (OGM + EGM) for 21 days, and then five 
samples of each group were subcutaneously implanted in the nude mice (two samples per 
mouse and 10 mice in total). The printed PCL/HAp scaffold alone served as control. For the 
surgery, the mice were deeply anesthetized, and one dorsal incision was made, lateral to the 
spine. Two subcutaneous pockets were made from this single incision, one on each side of 
the mouse, using blunt dissection. The scaffold implants were gently inserted into the 
subcutaneous pockets. The single skin incision was closed with wound clips, and the mice 
were monitored closely to ensure full recovery from anesthesia. All of the animals were 
sacrificed after 4-week implantation.
Histological and immunohistochemical staining
Cell-laden hydrogels were fixed in 4% paraformaldehyde, and printed PCL/HAp scaffolds 
with cells were fixed in 10% neutralized formalin overnight. The PCL/HAp scaffold samples 
were embeded in optimal cutting temperature (OCT) compound (Fisher Scientific) and 
cross-sectioned (~10 μm in thick) using a cryosectioner (Leica). H&E staining was 
conducted for implanted scaffolds. For immunohistochemical staining, the samples 
(hydrogels or sectioned slides) were permeabilized in 0.2% Triton X-100 then blocked with 
1% bovine serum albumin (BSA) overnight at 4°C. The samples were incubated with 
primary antibodies to α-smooth muscle actin (αSMA) (1:200, Sigma) and/or anti-human 
specific CD31 (1:100, Cell Signaling) overnight at 4°C. Secondary fluorescent antibodies 
and/or Alexa Fluor 488-conjugated phalloidin (1:40, Invitrogen) were incubated for 2 h, and 
nuclear counterstaining (Draq 5, 1: 1000, Thermo Scientific) was performed for 30 min at 
room temperature. The stained samples were imaged with a Zeiss 710 CLSM.
Quantitative estimation of cell migration rate and microvessel density
The cell migration rate in spheroid encapsulated hydrogels was quantified by measuring the 
migration distance from the edge of the spheroids using Image J software (NIH). Three 
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independent spheroid encapsulations were performed for each group, and at least twenty 
distance measures were conducted for each image. Microvessel density and area within the 
constructs, after in vivo implantation, were calculated by using two images per sample from 
the images of five scaffold samples (totally, 10 images for each group). The microvessels 
were identified as luminal structures with CD31 positive cells, and microvessel areas were 
calculated by identifying and calculating CD31 (red) positive areas in each 
immunofluorescent staining image.
Statistical analysis
All quantitative data were expressed as mean ± standard deviation (SD). Pairwise 
comparisons between groups were conducted using ANOVA with Scheffé post-hoc tests in 
statistical analysis. A value of p < 0.05 was considered statistically significant.
RESULTS
3D co-culture of ADMSC and HUVEC within bioactive hydrogel
We first evaluated the morphology and gene expression of ADMSC and ADMSC-HUVEC 
co-culture (1:1 ratio) within bioactive hydrogels, consisting of Me-HA and Me-Gel, in 
different condition media, as shown in Figure 1(A). In GM, ADMSC alone only expressed 
alpha smooth muscle actin (αSMA) and were mostly negative for CD31, which is a marker 
for endothelial cells. [Figure 2(A)]. The addition of EGM significantly promoted the 
expression of vascularization related genes, like VEGFA, vWF and PECAM1 [Figure 2(B)], 
but ADMSC still expressed very limited CD31 in the hybrid media [Figure 2(A)]. For the 
co-culture system, obvious CD31 expression was observed, and the presence of ADMSC 
induced the HUVEC to form capillary-like structures [Figure 2(A)]. The expressions of 
VEGFA, vWF, and PECAM1 were upregulated by 69.2 ± 13.2 fold, 82.1 ± 13.5 fold, and 
22.8 ± 12.5 fold, respectively.
We further generated ADMSC spheroids or ADMSC-HUVEC spheroids and encapsulated 
them into Me-HA/Me-Gel hydrogels to assess cell migration and sprouting [Figure 1(B)]. 
All of the cells showed obvious migration from spheroids after 7-day culture [Figure 3(A)]. 
We found that the addition of EGM did not affect the ADMSC migration compared to the 
GM condition [Figure 3(A, B)]. The co-culture of ADMSC-HUVEC promoted cell 
migration and sprouting from the spheroid and showed significantly higher migration 
distance [Figure 3(A,B)]. QPCR results showed that co-cultured spheroids expressed more 
MMP1, MMP2, and MMP12, indicating that the co-cultured cells had better matrix 
digestion capacity. These results were consistent with the migration test.
3D printed PCL/HAp scaffolds
Both PCL and PCL/HAp have been successfully 3D printed.30–32 In our current study, we 
3D printed PCL scaffolds with 10% HAp. The scaffold had regular pores of around 500 μm 
and strands with a thickness of 350–450 μm, based on light microscopy an SEM [Figure 
4(A,B)]. All of the design and printing processes are controllable, and the PCL/HAp 
scaffolds were 3D printed with different patterns to control the porosity and mechanical 
properties (Supporting Information Figure S1). Most of the HAp particles were embedded 
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inside of the PCL polymer, rather than on the surface [Figure 4(C)], during the melting and 
extrusion process. The compressive modulus of the PCL scaffold was slightly higher than 
that of the PCL/HAp scaffold, but did not meet the level of statistical significance. [Figure 
4(D)].
In vitro vascularization within 3D printed scaffolds
We 3D printed PCL/HAp scaffolds and encapsulated ADMSC or ADMSC-HUVEC within 
the Me-HA/Me-Gel hydrogel around PCL/HAp scaffolds [Figure 1(C)]. The whole 
constructs were conditioned in hybrid media with OGM and EGM. The cell-laden hydrogels 
remained intact around and inside the scaffolds through 21-day of culture. Similar to culture 
in gel alone, most ADMSC cultured in the composite scaffold did not express CD31 [Figure 
5(A)]. On the printed scaffold surface, the co-cultured ADMSC-HUVEC cells became 
confluent after 21-day culture and stained positive for CD31 [Figure 5(A)]. The 
encapsulated HUVEC formed microvessel-like structures within the constructs. Gene 
expressions of VEGFA, PECAM1, CDH5, and vWF were all significantly upregulated in the 
co-cultured constructs [Figure 5(B)], but there was no significant difference between the 
ADMSC-HUVEC surface seeding group and the encapsulation group.
In vitro osteogenic differentiation of ADMSC-HUVEC co-culture in 3D printed scaffolds
Next, we evaluated the osteogenic ability of ADMSC and ADMSC-HUVEC to determine 
whether or not co-culturing affects osteogenic differentiation in vitro. All constructs stained 
positive for alkaline phosphatase (ALP), revealing that all the constructs expressed 
substantial ALP [Figure 6(A)]. Also, the ALP activity significantly increased with 
increasing culture time from day 7 to day 21 for all the three groups [Figure 6(B)], but there 
were no significant differences between different groups. QPCR results showed that surface 
seeded ADMSC-HUVEC expressed slightly more osteogenic differentiation markers (ALP, 
Runx2, OCN, and OPN), but no statistical difference was observed. These results indicate 
that the co-culture and the use of EGM did not affect the in vitro osteogenic differentiation 
of MSC.
In vivo formation of vascular networks and microvessel density
In order to determine the capacity of the vascular network formation within 3D printed 
PCL/HAp in vivo, we surgically implanted cell-laden constructs into immunodeficient mice 
for 4 weeks. Printed acellular scaffolds were used as the control. All of the cell-laden 
constructs were conditioned in hybrid media consisting of OGM and EGM for 21 days 
before implantation. Figure 7(A) shows the macroscopic views of different scaffolds after 
explantation. None of the constructs evoked noticeable host inflammatory response. The 
acellular PCL/HAp scaffold showed very limited blood vessel infiltration. In contrast, the 
scaffolds with ADMSC-HUVEC surface seeding and encapsulation showed extensive blood 
vessels along the channel areas. H&E staining in Figure 7(B) show that the acellular 
scaffolds were infiltrated with some host cells, while the scaffolds with encapsulated 
ADMSC showed small remnants of hydrogels (hollow arrows). Both ADMSC-HUVEC 
surface seeding and encapsulation scaffolds were densely populated with cells (both host 
cells and pre-seeded/encapsulated cells) throughout the samples [Figure 7(B)]. As indicated 
in Figure 3, the co-culture of ADMSC-HUVEC expressed more MMP1, 2, 12 and thus 
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remodeled the matrix more quickly. This is probably why the constructs were populated 
with more cells and less matrix. The scaffolds with encapsulated and surface seeded 
ADMSC-HUVEC showed extensive microvascularity. In addition, many murine 
erythrocytes [white narrow arrows, Figure 7(B)] were also observed within the microvessels, 
indicating the integration of formed lumens with existing host vasculature. The perfused 
microvasculature stained positive for human CD31, which was stained by human specific 
anti-CD31 antibody, suggesting that the cells along the lumens were of human origin. In 
contrast, there were significantly fewer CD31 positive microvessels within the scaffolds with 
ADMSC alone. Although H&E staining demonstrated some vascular structures in the 
acellular scaffold group, no obvious human CD31 positive microvessels were observed. This 
indicates that the microvasculatures observed in H&E staining were probably of mouse 
origin.
Quantification of the microvessel density and area distribution resulted in statistically 
significant differences among the three groups [Figure 7(D,E)]. The human CD-31 positive 
microvessel density was similar in the ADMSC-HUVEC surface seeding and encapsulation 
groups. This was significantly higher than in the ADMSC encapsulated scaffolds [Figure 
7(D)]. There are probably multiple affecting factors, and one of the reasons is that the 
hydrogel could block the pores of the scaffold, which would affect the nutrition 
transportation and, to a certain degree, counteract their positive effects as vascular bed. The 
distribution of ingrowing neo-vessels seemed more homogeneous within the ADMSC-
HUVEC surface seeded scaffolds [Figure 7(E)]. In the ADMSC-HUVEC encapsulated 
scaffolds, both median and average lumen sizes (163.1 ± 56.7 μm2 and 337.0 ± 130.3 μm2) 
were significantly larger than those in the scaffolds with ADMSC (83.3 ± 16.2 μm2 and 
146.0 ± 42.3 μm2) or ADMSC-HUVEC surface seeding (83.3 ± 16.2 μm2 and 112.5 ± 64.8 
μm2).
DISCUSSION
Prevascularization has been shown to be a promising strategy to establish some vascular 
supply prior to implantation and to promote subsequent new bone formation.7,33,34 Although 
3D printed PCL/HAp scaffolds have been widely fabricated and used, most of them focused 
on the osteogenic differentiation of osteoblasts and MSC.35,36 In our current study, we 
combined 3D printing with a co-culture of EC and MSC and focused on the capacity of 
osteogenic differentiation and vascularization of the constructs. We implemented bioactive 
hydrogels consisting of Me-HA and Me-Gel as cell carriers to encapsulate the co-cultured 
cells. We hypothesize that the incorporation of HUVEC facilitates the prevascularization in 
the 3D printed scaffolds and that the hydrogel encapsulated cells promote superior 
microvessel formation when compared to surface cell seeding. Our previous studies have 
demonstrated that Me-HA/Me-Gel hydrogels have tunable stiffnesses37 and can be 
incorporated with conjugated growth factors.27 Chen et al. reported that the extent of the 
vascular network formation was significantly altered by the degree of Me-Gel 
methacrylation which mainly affected the hydrogel stiffness.38 We used Me-HA/Me-Gel 
hydrogels with relatively low level of stiffness (1.41 ± 0.27 kPa) in our study and 
demonstrated that the hydrogels supported the formation of capillary network structures.
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The 3D printing techniques have been applied to generate clinically relevant geometries for 
accurately shaped bone reconstruction.39–41 We implemented PCL/HAp composite materials 
and generated porous scaffolds, which have controllable patterns with the ability to replicate 
the complex defect anatomy of the mandible (Supporting Information Figure S1). HAp were 
mostly within the strands during the melting and printing process and had limited effects on 
mechanical properties and cell behavior. Larger amounts of HAp can be incorporated, and 
further surface modification can be conducted in future studies to improve the mineralization 
process. The porous printed scaffolds allowed for surface cell seeding and hydrogel 
encapsulation. The cell-laden macromer precursors can penetrate into the scaffolds and form 
uniform hydrogels around the printed PCL/HAp scaffolds after photocrosslink. Therefore, 
our composite scaffold system is composed of a mechanically robust porous matrix, which 
supports the maintenance of the bone defect and initial bone ingrowth, and a soft hydrogel, 
which supports vascular sprouting.
Co-culture of MSC and EC is commonly utilized for co-seeding on biologic scaffolds for 
bone regeneration.42,43 Surface seeding may result in non-uniform cell distribution, 
especially for large bone grafts. Animal derived extracellular matrix (ECM) proteins, such as 
collagen and fibrin, are used as cell or growth factor carriers for cell encapsulation and 
growth factor delivery within porous bone scaffolds.44,45 We implemented a more tunable 
Me-HA/Me-Gel hydrogel system for the cell encapsulation and directly compared the 
vascularization capacity with the surface seeded ADMSC and HUVEC. It is important to 
compare these strategies to better design and fabricate cell-laden scaffolds. Our results show 
that encapsulation within engineered vascular beds did not significantly upregulate 
vascularization gene expression, but did improve the microvessel formation in vitro and 
promoted larger and denser lumen formation that are of human origin. The formed 
microvascular vessels within the hydrogels were not only due to host blood vessel invasion, 
but also developed from the implanted human cells. In both ADMSC-HUVEC surface 
seeding and encapsulation groups, murine erythrocytes were observed within formed 
microvessels, indicating the functional integration with the host-murine vasculature.
The vascularization capacity of ADMSC remains unclear: some studies have shown that 
ADMSC alone can form microvascular structures in vitro,45,46 while others have 
demonstrated that ADMSC alone have no effect, and may impair the vascularization when 
ADMSC were pre-differentiated into an osteogenic lineage.47,48 The results of our current 
study show that ADMSC have a limited capacity to differentiate to CD31 positive EC and 
form capillary-like structures in vitro and in vivo. The angiogenic potential of ADMSC is 
mediated by matrix components,49,50 topography,51 pre-differentiation status,52 and 
biochemical and biophysical stimuli.47,53 In the co-culture system, many studies show that 
ADMSC can facilitate the vasculogenesis of EC in vitro54,55. Direct contact of EC and 
ADMSC is essential for mature vascular network formation, as ADMSC contribute to vessel 
stabilization by expressing the pericyte marker.56 Our results also demonstrate that co-
cultured ADMSC and HUVEC expressed more ECM degradation enzymes, which promote 
cell migration and capillary network formation.
The effect of co-culture on osteogenic differentiation is another important issue for BTE. 
Kim et al. reported that co-culture of MSC and HUVEC enhanced the osteogenic 
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differentiation of MSC in a 2 D culture, and that osteogenesis was further enhanced on the 
matrix with nanotopographic features.57 In contrast, Meury et al. showed that HUVEC 
inhibited osteoblastic differentiation of MSC in OGM and hybrid medium.58 In our current 
study, we demonstrate that co-culture of ADMSC and HUVEC, in both 2 D surface culture 
and 3D encapsulation, did not affect osteogenic differentiation of ADMSC compared to the 
ADMSC alone group. It has also been reported that the temporal variation of the culture 
environment and culture sequence might affect the osteogenesis and vascularization as well.
59,60 Development of vascularization prior to osteogenesis can better promote the osteogenic 
induction, thus suggesting that further effort should be made to synergize vascular 
development and osteogenesis. In the current study, we used hybrid media consisting EGM 
and OGM, and the sequential exposure to EGM and OGM was not adequately considered, 
which could create vessels and bone in their highest capacities after optimization of the best 
order and culture time. Future study will focus on determining how the prevascularization 
affects bone regeneration in a rabbit model with large craniofacial defect.
CONCLUSIONS
In our current study, we generated composite scaffolds consisting of 3D printed PCL/HAp 
and bioactive hydrogels for the prevascularization of engineered bone constructs. The co-
culture of ADMSC and HUVEC promoted in vitro vascularization, cell migration, and 
sprouting, but did not significantly affect osteogenesis. The Me-HA/Me-Gel hydrogels 
provide an engineered vascular bed and facilitated the formation of microvessels and 
vasculatures with both human and mouse origin. Our strategy may help in prevascularization 
of patient specific constructs in vitro to achieve rapid anastomosis in vivo and enhance bone 
repair.
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Schematic of experimental design. (A) Homogeneous cell encapsulation within Me-HA/Me-
Gel hydrogels: ADMSC or ADMSC-HUVEC and hydrogel precursors were loaded into 
silicone molds and subsequently exposed to 365 nm UV light for 60 s. The cell-hydrogel 
constructs were maintained in GM, hybrid media (GM and EGM) for 14 days; (B) Cellular 
spheroid encapsulation within hydrogels: ADMSC or ADMSC-HUVEC cell spheroids were 
fabricated first and then encapsulated within the hydrogels. The spheroid laden constructs 
were conditioned in GM or hybrid media for 7 days; (C) Composite constructs: PCL/HAp 
scaffolds were first 3D printed, then the printed scaffolds were incorporated with cell laden 
hydrogels. ADMSC or ADMSC-HUVEC were encapsulated. ADMSC-HUVEC were also 
surface seeded onto the printed PCL/Hap scaffolds. All of the constructs were conditioned in 
hybrid media with OGM and EGM for 21 days before further characterization or 
subcutaneous implantation.
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3D Co-culture of ADMSC and HUVEC within the hydrogel promoted capillary network 
formation and vascularization gene expression. (A) Representative immunohistochemical 
(IHC) staining for αSMA (red), CD31 (green) and nuclei (blue) within cell laden hydrogels 
after 14-day culture; (B) qPCR analysis of VEGFA, vWF and PECAM1 in cell laden 
hydrogels after 14-day culture. Relative gene expression is presented as normalized to 18S 
and expressed relative to ADMSC in GM (n = 3; bars that do not share letters are 
significantly different from each other; p < 0.05). ADMSC or ADMSC-HUVEC were 
encapsulated and conditioned in GM or GM and EGM.
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3D co-culture of ADMSC and HUVEC spheroids within hydrogel promoted cell migration. 
(A) Representative images of phalloidin staining for F-actin (green) and nuclei (blue) within 
spheroid laden hydrogels after 7-day culture (scale bar: 500 μm); (B) cell migration distance 
from encapsulated spheroids (**p < 0.01); (C) qPCR analysis of MMP1, MMP2 and 
MMP12 in spheroid laden hydrogels after 7-day culture. Relative gene expression is 
presented as normalized to 18S and expressed relative to ADMSC in GM (n = 3; bars that do 
not share letters are significantly different from each other; p < 0.05). ADMSC or ADMSC-
HUVEC spheroids were encapsulated and conditioned in GM or GM and EGM.
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3D printed PCL/HAp scaffold. (A) Representative image of 3D printed PCL/HAp scaffold 
with 10% of HAp nanocrystals; (B, C) SEM images of printed PCL/HAp scaffold (scale bar: 
500 μm). The PCL/HAp scaffold had regular pores of around 500 μm and strands with a 
thickness of 350–450 μm; (D) Compressive modulus of 3D printed PCL and PCL/HAp 
scaffolds.
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In vitro vascularization within 3D printed scaffolds. (A) Representative IHC staining for F-
actin (green), CD31 (red) and nuclei (blue) within cell laden hydrogels around 3D printed 
PCL/HAp scaffolds after 21-day culture (scale bar: 50 μm; white arrow indicates the 
formation of microvessel like structure); (B) qPCR analysis. Relative gene expression is 
presented as normalized to 18 S and expressed relative to scaffolds with ADMSC alone (n = 
3; bars that do not share letters are significantly different from each other; p < 0.05). 
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ADMSC or ADMSC-HUVEC were encapsulated and conditioned in hybrid media with 
OGM and EGM.
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Co-culture of ADMSC and HUVEC within 3D printed scaffolds did not affect osteogenic 
differentiation in vitro. (A) Representative images for ALP staining after 21-day culture 
(scale bar: 1 mm); (B) ALP activity (**p < 0.01); (C) qPCR analysis. Relative gene 
expression is presented as normalized to 18S and expressed relative to scaffolds with 
ADMSC alone. (n = 3). ADMSC or ADMSC-HUVEC were encapsulated and conditioned 
in hybrid media with OGM and EGM.
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In vivo vascularization within 3D printed scaffolds. (A) Overall view of explanted scaffolds 
after 4-week subcutaneous implantation (scale bar: 4 mm); (B) Representative images of 
H&E staining (scale bar: 200 μm). The wide, solid arrows indicate the formed microvessels 
with lumen structure and red blood cells inside. These microvessels can be of either human 
or mouse origin. The black, narrow arrows indicate the HAp particles. White, narrow arrows 
indicate the murine erythrocytes within blood vessels. The remnants of hydrogels are 
denoted by hollow arrow, and the asterisks indicate the PCL/HAp scaffold strand areas; (C) 
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IHC staining for human CD31 (red), αSMA (green), and nuclei (blue) within 3D printed 
scaffolds. The white, solid arrows indicate the stained cells/microvessles positive for human 
CD31. Very few human CD31 positive cells were observed in scaffold alone group, 
indicating that the formed capillaries were of mouse origin. The asterisks indicate the 
PCL/HAp scaffold strand areas; (D) Microvessel density of the scaffolds. The density was 
measured in vessels/mm2. (**p < 0.01); (E) Microvessel area distribution in the scaffolds. 
The microvessel density and microvessel area distribution were measure by quantifying the 
formed CD31 positive vascular-network.
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